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Curzerene (Cur) is the active ingredient of Smyrnium cordifolium extract both of which are capable of reducing the symptoms of 
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Introduction: The purpose of this study was evaluating the effect of Smyrnium cordifolium 
extract (SCE) and curzerene (Cur) on withdrawal syndrome in mice compared with clonidine. 
Methods: High-performance liquid chromatography (HPLC) was used to determine the active 
ingredients of S. cordifolium. To evaluate the effects of SCE and Cur, 64 mice were divided into 8 
equal groups. Groups 1, 2 and 3 were treated Cur (0.03, 0.06, 0.12 mg/kg, respectively). Groups 
4, 5 and 6 were treated with SCE (100, 200, 300 mg/kg, respectively). The seventh group received 
just morphine. Group 8 received morphine and clonidine (0.2 mg/kg). 
Results: The results of this study showed that Cur was the most important ingredient in the 
extract of the plant, and the hydroalcoholic extract yield of S. cordifolium was 17.55% (w/w). 
The dose of 100 mg/kg of extract (SCE100) and 0.03 mg/kg curzerene (Cur1) (P < 0.05), dose of 
200 mg/kg of extract (SCE200) and dose of 0.06 mg/kg curzerene (Cur2), (P < 0.01), dose of 300 
mg/kg of extract (SCE300) and dose of 0.12 mg/kg of curzerene (Cur3) (P < 0.001) decreased 
the symptoms compared to clonidine. Doses higher than 300 mg/kg of extract and 0.12 mg/
kg of Cur had fatal effects. All doses of SCE and Cur in comparison with the control group at 
significant level (P < 0.001) reduced the number of jumping, rearing and teeth chattering in 
morphine-dependent mice.
Conclusion: The findings suggest that SCE and Cur are capable of reducing the symptoms 
of withdrawal syndrome and their effectiveness may be more than clonidine in reducing the 
addiction withdrawal syndrome, which may have human therapeutic potential.
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Introduction
Opioids are the most effective medications to relieve 
pain, depression, anxiety and withdrawal syndrome (1). 
Addiction and abuse of opioids are of the most important 
economic and social problems in the world (2). Long-
term and repeated administration of opioids lead to 
tolerance and dependence and discontinuation of these 
substances causes signs such as pain, anxiety, aggression 
and withdrawal syndrome. 
Many studies have shown that the use of some medicinal 
plants can reduce the symptoms of drug discontinuation. 
In traditional medicine, many herbs such as Salvia 
limbata, Lavandula officinalis and Passiflora incarnata are 
used for their analgesic and hypnagogic effects (2). Also, 
Coriandrum sativum with narcolepsy and antianxiety 
effects is used in traditional medicine (3). In traditional 
Iranian medicine, Smyrnium cordifolium is used to treat 
anxiety and insomnia. There are limited reports regarding 
the analysis of S. cordifolium extract (SCE). In a study, by 
GC/MS, S. cordifolium essential oil was characterized by a 
high content of sesquiterpenes, most of them oxygenated 
sesquiterpenes with curzerene (16.9%) and curzerenone 
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(33.8%) as major constituent (4). According to some 
studies of the mechanisms involved in opioid tolerance 
and dependence, neurotransmitter systems such as nitric 
oxide (5), glutamate (6) dopamine (7), and receptors of 
stimulatory amino acids especially the glutamate receptors 
(NMDA) were of great importance. The role of NMDA 
has been proven in the opioid synaptic shaping process 
(8,9).
The genus Smyrnium is represented in the flora of Iran 
by only S. cordifolium Boiss species (Avendol), which is 
a biennial herb and widely distributed in the Zagrose 
mountains at an altitude of 1400-2000 m in the west and 
northwest of Iran. This plant has many nutritional and 
medicinal uses (10).
In traditional medicine of Iran, S. cordifolium is used to 
treat anxiety, pain, insomnia and withdrawal syndrome. A 
number of medicinal properties, e.g. diuretic, restorative 
and counteracting renal calculus have been described 
for all parts of the plant. Additionally, the fleshy stems of 
the plant are used as vegetables (4). The purpose of this 
study was to investigate the effects of SCE and curzerene 
(Cur) on withdrawal syndrome in mice compared with 
clonidine.
Materials and Methods 
Extraction
The aerial parts of S. cordifolium used for the present 
study were collected by the authors during the flowering 
stage between February and March, 2017 from the 
Ghalajah Mountains of Ilam province in West of Iran. A 
voucher specimen of the collection was identified by Dr. 
Attar F. (Tehran University, Biology department, Iran) 
and deposited at the Department of Biology, Ilam Azad 
University, Iran (herbarium number IAU-9408). The 
aerial parts of the plant were dried in shade for a week and 
exposed to airflow at room temperature, then powdered 
with an electric mill. The plant extract was prepared by 
Soxhlet extraction method and powered. Each 15 g of 
powder was crushed into a thimble paper and extracted 
with 250 mL of 70% ethanol. The process of extraction 
continued until the solvent in siphon tube of the extractor 
became colorless (about 48 hours). In order to evaporate 
excessive solvent, the sample was then concentrated in a 
rotary vacuum distiller under negative pressure at 50°C. 
The extract was incubated at 30-40°C until the solvent was 
completely isolated from the extract and powdered. The 
powder was preserved in sterile bottles at -20°C until use 
(11).
Extract Analysis and Determination of Active Component 
by HPLC 
High performance liquid chromatography (HPLC) was 
used to determine the Cur of S. cordifolium in comparison 
to standard Cur (ChemFaces Co., No: 17910-09-7). The 
HPLC system was Knauer (model 1000), consisted of 
a variable wavelength UV detector (model 2800), used 
at a wavelength of 230 nm with the outputs recorded 
and analyzed using a compatible software (ChromGate, 
Knauer), Nova-Pak C18 Column, 60Å, 4 µm, 4.6 mm 
X150 mm [WAT044375]. The mobile phase consisted of 
acetone, ethanol and acetonitrile solvents. The volume of a 
single injection was 1 μL. After each injection, the column 
was equilibrated for 15 minutes. The stock solutions 
of 5 standards were made at concentration of 1 mM in 
a final volume of 10 mL of ethanol. In order to plot the 
calibration curve, working solutions of mixed standards 
at the concentrations of 3.1, 6.2, 12.5, 25 and 50 μM were 
made by dilution of stock solution in volumetric flasks 
with the mobile phase. Then the standards were injected 
into the HPLC (12).
Animals
Sixty-four adult male mice (25-30 g) obtained from the 
Pasteur Institute (Tehran, Iran) were divided into 8 groups, 
each group consisting of 8 numbers. The animals were 
individually housed in eight ones per cage with a 12/12 
hours light/dark cycle and having free access to food and 
water. All experiments were performed in accordance with 
the Guiding Principles for Care and Use of Laboratory 
Animals of the Faculty of Medicine, Ilam University.
Drugs
Morphine and naloxone ampoules, and clonidine 
hydrochloride tablets were obtained from Tolid Daru Co, 
Tehran-Iran, and Cur from ChemFaces Co.
Development of addiction to morphine in mice
The mice were injected subcutaneously with morphine 
twice daily for 7 days. The dose of morphine on days 1 and 
2 was 2.5 mg/kg; this dose was doubled every day to reach 
about 40 mg/kg on day 6. On day seven, the mice received 
the last injection of morphine, 50 mg/kg (11).
Study of morphine addiction signs in mice
Mice of all groups received 3 mg/kg (i.p.) naloxone 4 hours 
after the last injection of morphine on day 7 of morphine 
treatment. Immediately each mouse was placed in a 
transparent cylinder (30 cm height, 20 cm in diameter) 
to observe the frequency of withdrawal manifestations 
(jumping, teeth chattering, rearing) for 30 minutes (11).
Simultaneous effect of morphine and Curzerene on 
withdrawal syndrome in mouse
Groups 1 (Cur1), 2 (Cur2), and 3 (Cur3) were treated 
intraperitoneally with different doses of Cur (0.03, 0.06, 
0.12 mg/kg, respectively) and morphine.
Effect of co-administration of SCE and morphine on 
addiction withdrawal syndrome in mice
Groups fourth (E100), fifth (E200) and sixth (E300), were 
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treated with different doses of SCE (100, 200, 300 mg/kg, 
by gavage, respectively) and morphine. 
Effect of co-administration of clonidine hydrochloride and 
morphine on the development of morphine dependence 
and expression of withdrawal syndrome
In group 7 clonidine hydrochloride (CLO, 0.2 mg/kg, 
i.p.) was administered concurrently with morphine, twice 
daily for 6 days; and on day 7 they were injected the last 
dose of clonidine with morphine concurrently 4 hours 
before the naloxone challenge. The effect of Clonidine on 
the attenuation of morphine dependence was assessed by 
comparing the frequency of the behavioral withdrawal 
signs of animals in group 7 and also the ability of SCE 
and Cur in attenuation of morphine dependence versus 
clonidine was assessed by comparing groups 1, 2, 3, 4, 5 
and 6 (13). The mice in group 8 received just morphine as 
positive control group.
Statistical analysis
Analysis of the data was done by SPSS 19 and Excel 2015 
software. Statistical analysis was performed to compare 
withdrawal syndrome behavioral manifestations, using 
one-way analysis of variance (ANOVA) and t test analysis 
for the different groups. The data were represented as 
mean ± SEM. The level of significance  was set at P < 0.05.
Results
Yields of SCE were obtained as being 17.55% (w/w). The 
extract analysis was performed to confirm the passive 
value of the HPLC device on the Nova-Pak C18 column 
(60Å, 4 μm, 150X4.6 mm) and UV detector using a mobile 
phase including acetone, ethanol and acetonitrile solvents. 
In order to plot the calibration curve (Figure 1), for 
quantitative measurements of Cur, concentrations of 3.1, 
6.2, 12.5, 25 and 50 μM were prepared from Cur standard 
and after filtration, each one injected three times into 
HPLC apparatus. The area under the curve was plotted 
against the injection volume. The regression line and 
standard correlation coefficient of corrosion coefficient 
were calculated. The Cur output of the standard Cur 
medium appeared at a mean retention time of 8.183 
minutes.
The regression line equation was defined as 
y=23180x+85361. The correlation coefficient of Cur 
standard (r2) was r2=0.9964 between the absorbance value 
at 230 nm wavelength from the standard curve (Figure 
1), which by placing the surface area values below the 
curve obtained for Cur in the equation of regression line, 
the value x, which is the same concentration of the SCE 
sample, was determined to be 6.95 μmol.
In the curve obtained from 3 times injection of SCE, 
the average peptide inhibition time of the extract was 
7.717 minutes (Figure 2). The preceding and subsequent 
peaks correspond to the peak of the solvents at about the 
retention time. The HPLC results of the extract showed 
that Cur had the highest amount of its constituent 
material, as shown in Figure 2.
Repeated administration of morphine produced 
physical dependence as assessed by a characteristic set of 
behavioral responses including teeth chattering, jumping 
and rearing, following naloxone challenge. Repeated 
co-administration of SCE with morphine decreased 
significantly the frequencies of the signs of withdrawal 
syndrome compared with frequencies of withdrawal 
manifestations of morphine-dependent mice treated with 
clonidine. As shown in Figures 3 and 4, naloxone induced 
a highly significant increase in the mean frequency of 
rearing, teeth chattering, jumping in dependent mice 
treated with Cur and SCE compared with the clonidine 
and the control groups. 
Figure 3 clearly shows that chronic morphine injection 
on the mean number of jumping during morphine 
withdrawal in Cur1 (mean of jump 22.75) significantly 
decreased the level (P < 0.05). Cur2 significantly decreased 
the level (P < 0.01) compared to the clonidine group. In the 
Cur3 group (mean jump of 15.75), there was a significant 
decrease (P < 0.001) compared to the clonidine group. 
However, the mean number of jumps in these groups 
was significantly lower than the control (mean of jump 
40.5) group. As shown in Figure 3, increasing the dose of 
 

















Figure 1. Calibration curve of Cur at concentrations of 3.1, 6.2, 12.5, 
25 and 50 μm
Figure 2. Curve obtained from injection of SCE obtained by HPLC 
analysis
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Cur decreased significantly the frequency of the signs of 
withdrawal syndrome (group Cur1 compared with Cur2 
and group Cur2 compared with Cur3).
Similarly, statistical analysis showed that chronic 
morphine injection during morphine withdrawal in Cur1, 
Cur2 and Cur3 groups significantly decreased the number 
of rearing compared to the clonidine group.
Also, Figure 3 distinctly shows that chronic morphine 
injection reduced the mean number of teeth chattering 
during morphine withdrawal in Cur1, Cur2 and Cur3 
groups compared to the clonidine group. However, the 
mean number of jumps in all groups was significantly 
lower than the control (mean of teeth chattering 45.5) 
group (P < 0.001). One disadvantage was detected at a 
dose of 0.12 mg/kg Cur which increased the mortality rate 
of mice in co-administration with morphine.
Results showed that orally administration of SCE by an 
NG tube at concentrations of 100, 200 and 300 mg/kg 
significantly reduced the number of jumping episodes 
in morphine-dependent mice. Clonidine, as a reference 
drug, caused a significantly reduced number of jumping, 
rearing and teeth chattering episodes.
Figure 4 obviously shows that chronic morphine 
injection on the mean number of jumping during 
morphine withdrawal in SCE100 (mean of jump 20.38) 
significantly decreased the level (P < 0.05). SCE200 (mean 
of jump 16.88) significantly decreased the level (P < 0.01) 
compared to the clonidine group. In the SCE300 group 
(mean jump of 8.13), there was a significant decrease 
(P < 0.001) compared to the clonidine group. The mean 
number of jumps in these groups was significantly lower 
than the control group.
Statistical analysis clearly showed that chronic morphine 
injection reduced the mean number of teeth chattering 
during morphine withdrawal in the SCE100 (mean of 
teeth chattering 17) (P < 0.05), SCE200 (mean of teeth 
chattering 12.75) (P < 0.01) and SCE300 (mean of teeth 
chattering 7.38) (P < 0.001) compared to clonidine and 
control groups. Doses higher than 300 mg/kg of extract 
and 0.12 mg/kg of Cur had fatal effects. 
The mean number of rearing was significantly decreased 
in SCE100 (P < 0.05), SCE200 (P < 0.01) and SCE300 
(P < 0.001) groups in comparison to the clonidine group 
when morphine was discontinued (Figure 4). 
Discussion
This study showed that the main and effective component 
of SCE is one of the sesquiterpenes (a class of C15 
substance derived from 3 isoprene units) called Cur. This 
study showed that the SCE and the effective combination 
of the extract of this plant could be useful in reducing the 
symptoms of withdrawal syndrome.
Terpenoids and sesquiterpenes have the most diversity 
among plant compounds (14). So far, more than 40 000 
compounds have been identified with molecular structures 
and diverse biological activities. Most of them are 
produced by secondary metabolism (15). Phytochemical 
studies of S. cordifolium caused the identification of some 
sesquiterpenes, especially curzerenone and Cur, which 
had the highest amounts in its essential oil (16). Also, in S. 
perfoliatum plant, sesquiterpene germacrene, isopimarol, 
D-germacrone and β-pinene compounds have been 
reported (17). In another study, Maggi et al identified the 
compounds of isofuranogermacrene, Cur, germacrone, 
D-germacrene, isofuranodiene, β-phyllocladanal, 
α-pinene and β-pinene, from S. olusatrum (18). Amiri 
et al indicate that the major part of the essential oil of 
S. cordifolium was sesquiterpene compounds, of which 
Cur (16.9%) and curzerenone (33.8%) had the highest 
amounts, and the other compounds of this plant included 
D-germacrone 13% and isopimarol with 10.9% (4) that 
are consistent with the results of our research. Also, 
Figure 3. Mean of the jumping, rearing and teeth chattering.
Cur1: The group which received Cur (0.03 mg/kg) and morphine, 
Cur2: The group which received Cur (0.06 mg/kg) and morphine, 
Cur3: The group which received Cur (0.12 mg/kg) and morphine, 
CLO: The group which received clonidine (0.2 mg/kg) and 
morphine, Control: The recipient received just morphine. Each 
column represents the mean ± SEM (n=8). * P < 0.05, ** P < 0.01, 
and *** P < 0.001.
Figure 4. Mean of the jumping, rearing and teeth chattering.
SCE100: The group which received SCE (100 mg/kg) and 
morphine), SCE2: The group which received SCE (200 mg/kg) 
and morphine, SCE3: The group which received SCE (300 mg/
kg) and morphine, CLO: The group which received clonidine (0.2 
mg/kg) and morphine, Control: The recipients that just received 
morphine. Each column represents the mean ± SEM (n=8). * 
P < 0.05, ** P < 0.01, and *** P < 0.001.
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previous studies with GC-MS and GC-FID showed 
that S. cordifolium contained more than 16 substances 
that Cur with 65.26% of the plant extract composition 
and δ-cadinene with 14.3%, γ-elemene with 5.15%, 
curzerenone with 2.43%, and germacrone with 2.18% 
were other components of S. cordifolium (19).
Smyrnium cordifolium is used in traditional medicine 
by Iran to treat inflammatory, anxiety and insomnia. 
Although the anticonvulsant properties of S. cordifolium 
essential oil have been investigated (20), it is the first time 
that the reducing signs of addiction withdrawal effects of 
SCE and Cur were studied.
The results of this study indicate that the major part of 
the SCE contains Cur. Recently, the pharmacotherapy 
of opioid tolerance and addiction has drawn intensive 
interest. The results of this study showed that chronic 
administration of morphine for 7 days caused dependence 
and tolerance to the effects of this substance. These 
findings are consistent with the Zarrindast study (7). 
The results showed that treatment with different doses of 
SCE during the 7-day program with morphine, reduced 
the symptoms of addictive drug withdrawal syndrome in 
morphine-dependent mice. Terpenoids, sesquiterpenes 
and herbs containing these compounds exhibit anti-
nociceptive, anti-anxiety and sedative activities (21). 
Therefore, Cur and the compounds present in the SCE may 
be part of the anti-nociceptive and decreasing effects of 
withdrawal syndrome through various mechanisms such 
as GABAergic, opioidergic and serotonergic mechanisms. 
There are opioid receptors within the CNS as well as 
throughout the peripheral tissues. The μ, κ and δ opioid 
receptors are related to pain and addiction. The opioid 
receptors are attached to the G-protein and affect the 
opening of the ion channels, intracellular transmissions 
and protein phosphorylation. The general antagonist 
of these receptors (naloxone) is capable of inhibiting 
the analgesic effects of opioid receptors and preventing 
analgesia. Naloxone inhibits the effectiveness of analgesic 
drugs such as morphine. This drug tends to have the μ 
opioid receptor in the central nervous system, but less 
opioid receptors κ and δ (22). This may happen for 
dependence effects of morphine. 
Based on studies conducted with the activation of these 
receptors, calcium entry into the cell increases. Obviously, 
increasing intracellular calcium concentrations can 
activate some types of calcium-dependent secondary 
propagandists. This leads to several effects, such as 
facilitating the activity of Ca2+/calmodulin-dependent 
protein kinase II (CaMkII) (23), regulating positive 
feedback activity of protein kinase C (24), the activation of 
nitric oxide synthase (NOS), and finally, the production of 
nitric oxide (NO) (25). Nitric oxide is a nerve modulator 
derived from the L-arginine nitric oxide synthase enzyme. 
The NOS enzyme is activated by calcium-calmodulin, 
protein kinase II (CaMkII) (26). A lot of researches have 
suggested that NO is involved in inducing morphine 
tolerance and dependence. There is also evidence that 
NO can be co-administered with other neurotransmitter 
systems, such as the glutamatergic system and the NMDA 
receptor for its role (27,28). Also, the research shows that 
there is a two-way relationship between the production of 
NO and the release of dopamine (29). It seems that the 
SCE with an effect on the CNS and PNS might be effective 
in the treatment of anxiety, pain, insomnia, and reduce 
the symptoms of its addiction withdrawal syndrome. The 
present study showed that injection of Cur and SCE had 
a significant decrease in the number of jumping, teeth 
chattering and rearing in morphine-dependent mice 
in comparison to the Control and Clonidine groups. 
These results are, in part, consistent with the results of 
other studies (19). Creating a rapid dependence restricts 
the usefulness of morphine in long-term treatment, but 
Cur and SCE are thought to be good agonists for the 
replacement of morphine.
Central serotonergic nerves are of the neurological 
systems involved in opioid dependence. On the other 
hand, sesquiterpenes such as Cur may have analgesic 
properties, and as an activator of the CNS, by stimulating 
the anxiety interventionist system, are effective on the 
surface of the GABA (30). Hence, it is possible that SCE 
can reduce the symptoms of discontinuation of morphine. 
Previous studies have shown that discontinuation of 
morphine leads to a significant reduction in serotonin 
in several CNS regions, including dorsal raphe nuclei. 
Also, the electrical stimulation of the dorsal raphe nucleus 
and enhances the release of serotonin. Serotonin in the 
hypothalamus leads to stimulation of release enkephalins 
and decreases the withdrawal symptoms. Therefore, 
it seems that serotonin is one of the factors involved in 
physiological changes and behaviors involved in opiate 
withdrawal (31). Research has shown that terpenoids 
also have analgesic effects through interference with the 
opioid system (32). Probably effective compounds such as 
Cur and SCE have the ability to stimulate the serotonergic 
system. Therefore, according to the above, it can be 
justified that the SCE may reduce withdrawal symptoms 
by releasing serotonin.
The administration of naloxone as an opioid receptor 
antagonist has reduced the analgesic effect of the SCE 
and it has been stated that the analgesic effect of the SCE 
is probably related to the effect of the opioid system. 
Therefore, with chronic morphine administration, 
possibly endogenous opioids, including Met-enkephalin, 
are reduced. This reduction is apparent when naloxone 
is injected and the SCE showed to be able to prevent 
these symptoms. It can be argued that some of the SCE 
compounds such as Cur, with opioid-like properties, 
reduces morphine withdrawal symptoms, which is 
consistent with previous studies (33,34). 
Conclusion
It appears that the compounds present in S. cordifolium 
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extract such as Cur are capable of reducing the symptoms 
of withdrawal syndrome and their effectiveness may be 
more than clonidine. This may have human therapeutic 
potential.
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